Exciting news as another group proposes to explore telomerase therapy for the Cardio Vascular system. This no doubt follows on from DePhino et al work on the P53-telomerase-PCG-1 aging axis work which showed the effects of short telomeres on vascular aging (and other organs) and its direct link to Mitochondrial function and Stem cell Decline via the P53-telomerase-PCG-1 aging axis.
